Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Humanized Mice Improve CES Prodrug Translation
2026-09-08
The 2025 study of HD56 and HD561 shows how species-specific carboxylesterase activity can distort prodrug pharmacokinetics and weaken conventional in vivo–in vitro correlations. Humanized-liver mice produced the strongest translational relationship, supporting their use when human metabolic pathways are central to ester prodrug development.
-
Purmorphamine: From Smo Biology to Translation
2026-09-08
Purmorphamine is more than a pathway activator: it is a practical Smoothened agonist for testing how Hedgehog signaling connects receptor biology with osteogenic, neural, and sensory phenotypes. This thought-leadership guide outlines the evidence, experimental controls, and translational questions that can make Smo-directed studies more decision-ready.
-
Puromycin Aminonucleoside: A Causal Assay Framework
2026-09-07
Puromycin aminonucleoside can do more than generate proteinuria: it can help researchers connect exposure, podocyte injury, and glomerular pathology through a tiered causal assay strategy. This guide integrates renal model design with an evidence-based framework for interpreting transporter, morphology, viability, and epigenetic readouts.
-
Puromycin aminonucleoside for Podocyte Models
2026-09-07
Build more reproducible podocyte injury, proteinuria, and FSGS workflows with Puromycin aminonucleoside, while separating validated model readouts from exploratory proteomics. This guide combines reagent handling, renal phenotyping, transporter-aware controls, and a practical route to aggregate-sensitive target discovery.
-
BIRB 796 and the Next Logic of p38α Inhibition
2026-09-05
BIRB 796 (Doramapimod) illustrates how selective allosteric control of p38α MAPK can sharpen inflammation research while raising a more consequential translational question: does inhibitor binding merely suppress kinase activity, or can it reshape the dephosphorylation landscape? This article connects product pharmacology, phosphatase biology, assay design, and clinical caution for researchers developing mechanistically rigorous p38 MAPK studies.
-
Panobinostat: Epigenetics Meets Proteotoxic Stress
2026-09-04
Panobinostat (LBH589) is a broad-spectrum HDAC inhibitor for connecting chromatin remodeling with apoptosis and proteotoxic stress. This article translates recent prostate cancer findings into practical assay-design decisions without overstating combination evidence.
-
Nonivamide: From TRPV1 Signaling to Translation
2026-09-04
Nonivamide is more than a capsaicin analog for receptor activation. Its value for translational research lies in connecting TRPV1 pharmacology with two experimentally distinct outcomes: cancer cell growth inhibition through mitochondrial apoptosis-associated signaling and neuroimmune regulation through a somato-autonomic reflex. This article examines the mechanistic rationale, evidence boundaries, practical workflow considerations, and strategic opportunities for using Nonivamide in glioma research, small cell lung cancer models, and inflammation-focused studies without overstating its clinical maturity.
-
Amorolfine Hydrochloride for Fungal Studies
2026-09-03
Use Amorolfine Hydrochloride as a membrane-focused perturbation tool for linking fungal growth, cell-surface integrity, and ploidy. This workflow combines solvent-aware handling with ploidy-stratified assays to support mechanism studies and antifungal resistance research without confusing exploratory findings with clinical evidence.
-
Reserpine N1867: Practical Lab Workflow Guide
2026-09-03
Reserpine (SKU N1867) helps laboratories standardize solvent selection, stock preparation, storage, and quality control in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. It is intended for controlled research use only and should not be used for diagnostic, therapeutic, or other medical applications.
-
AZD1390 and the Hidden Logic of G4 Stress
2026-09-02
A mechanistic and translational perspective on how AZD1390, an ATM kinase inhibitor, can be used to connect G-quadruplex replication stress with radiation response in glioma and lung cancer models.
-
Triacetin Digestion and Absorption: Liver Signaling
2026-09-02
This rat study clarifies how the short-chain triacylglycerol triacetin is digested, absorbed, and connected to hepatic metabolism. Its central finding is that triacetin is degraded in the upper gastrointestinal tract into acetate and glycerol, which appear to function both as metabolic substrates and as regulators of liver energy-related gene expression.
-
Leucomycin Workflows for MIC and Resistance
2026-09-01
Leucomycin (kitasamycin) connects ribosome-focused translational inhibition studies with practical MIC testing and macrolide resistance characterization. This workflow emphasizes solvent control, isolate-specific interpretation, and analytical quality checks that improve antibacterial drug discovery decisions.
-
Cy5-UTP for RNA Probe Synthesis and FISH
2026-09-01
Cy5-UTP enables direct, far-red visualization of RNA generated by T7 in vitro transcription, streamlining FISH, array, and RNA-delivery assay workflows. This guide connects practical labeling decisions with targeted PTEN mRNA delivery research while emphasizing controls, optimization, and interpretation limits.
-
Rhodamine B Workflows for Imaging and Nanomedicine
2026-08-31
Rhodamine B converts cell labeling, microscopy, and nanoparticle-tracking questions into measurable fluorescence workflows. This guide pairs practical assay setup with lessons from a trypsin-responsive pancreatitis nanomedicine study, while clearly separating validated evidence from recommended starting conditions.
-
Wortmannin for PI3K and Autophagy Assays
2026-08-31
Wortmannin gives researchers a potent, irreversible way to test whether PI3K-dependent signaling contributes to autophagy, apoptosis, and Akt activation. This guide translates parasite–macrophage findings into practical workflows while defining concentration windows, controls, and troubleshooting steps for cancer research and cell-based assays.